Xanomeline
Alternative Names: LY 246708; Memcor; NNC 110232Latest Information Update: 21 Mar 2024
Price :
$50 *
At a glance
- Originator Novo Nordisk
- Developer Eli Lilly and Company
- Class Antidementias
- Mechanism of Action Muscarinic M1 receptor agonists; Muscarinic M4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease